Table 2 Patient demographic and clinical characteristics in the full sample

Mean ± SD age, years

60.8 ± 16.5

Male, n (%)

949 (61.5)

White, n (%)

1432 (92.9)

Mean ± SD CCI score

2.3 ± 2.2

Primary reason for hospitalization is treatment of MRSA cSSTI, n (%)

1249 (81.0)

Timing of cSSTI index date, n (%)

  At hospital admission

1282 (83.1)

  1–3 days after admission

49 (3.2)

  ≥4 days after admission

211 (13.7)

Type of cSSTI, n (%)

  Surgical site infection or posttraumatic wound

400 (25.9)

  Major abscess

271 (17.6)

  Infected ulcer

381 (24.7)

  Deep or extensive cellulitis

406 (26.3)

  Other (including infected burn)

84 (5.4)

cSSTI location, n (%)

  Head/skull/neck

63 (4.1)

  Torso/abdomen

325 (21.1)

  Upper extremity

232 (15.0)

  Lower extremity

922 (59.8)

Sepsis, severe sepsis, or septic shock during cSSTI episode, n (%)

265 (17.2)

Surgical procedures for treatment of cSSTI, n (%)

597 (38.7)

Mean ± SD number of procedures among patients with any procedures

0.4 ± 0.6

Patient switched from IV-to-oral inpatient MRSA-active antibiotic treatment, n (%)

197 (12.8)

Patient received MRSA-targeted therapy at discharge, n (%)

514 (33.3)